Trihal Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 131.83%
(FY 2023)
- Ebitda 71.79%
(FY 2023)
- Net Worth 33.67%
(FY 2023)
- Total Assets 967.67%
(FY 2023)
About Trihal Pharma
The Corporate was formerly known as Trihale Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Mangilal, Amit Bansal, Shekhar Bhuwania, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290MH2021PTC359068
- Company No.
359068
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Trihal Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shekhar Bhuwania  | Director | 16-Apr-2021 | Current |
| Manish Mangilal | Director | 01-Feb-2022 | Current |
| Amit Bansal | Director | 01-Feb-2022 | Current |
| Madhur Gupta | Director | 15-Jun-2022 | Current |
Financial Performance and Corporate Structure Insights of Trihal Pharma.
Trihal Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 131.83% increase in profit. The company's net worth Soared by an impressive increase of 33.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trihal Pharma?
In 2022, Trihal Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trihal Pharma?
Trihal Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trihal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trihal Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
